Latest Announcements

Entero Healthcare Solutions Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, along with the grant of fresh employee stock options and the opening of the trading window.

Godavari Biorefineries Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, showing a turnaround in quarterly performance despite industry headwinds. The company's Bio-based Chemicals business maintained strong momentum, with revenue growing by approximately 39% year-on-year and segment EBITDA increasing by approximately 47% year-on-year.

Capfin India Ltd has announced the outcome of its Board Meeting held on November 4, 2026, where the Board considered and approved the Un-audited Financial Results for the quarter and half year ended September 30, 2026, along with the Limited Review Report issued by M/s. Mehra Goel & Co. LLP.

Lippi Systems Ltd-$ has announced unaudited financial results for the quarter ended 30th September 2026, with the Board of Directors approving the results at its meeting on November 4, 2026.

Shivansh Finserve Ltd has announced its unaudited financial results for the quarter ended September 30, 2026, showing a net loss of Rs. 35.84 lakhs and a basic earnings per share of Rs. 0.57.

Haria Exports Ltd has announced its unaudited financial results for the quarter ended September 30th, 2026, with a net profit of Rs. 380 lakhs and a total comprehensive income of Rs. 380 lakhs. The company's revenue from operations was Rs. 1078 lakhs, and its other income was Rs. 1078 lakhs. The company's basic and diluted earnings per share were Rs. 0.02 and Rs. 0.01, respectively.

Aurobindo Pharma Ltd has announced its Q2 FY27 financial results, with revenue of ₹10,263 Cr, a 23.9% growth YoY, and highest-ever quarterly EBITDA of ₹2,156 Cr at a margin of 21.0%. The company has also launched 10 products in the US market and generated net cash flow of US$ 146mn during the quarter.

Dr. Lal Path Labs Ltd. has informed the Exchange about the availability of the audio recording of their earnings conference call with investors/analysts for Q2 & H1 FY27 on their website.

ICRA Ltd has released an audio recording of its earnings conference call, providing insights into its recent financial performance and future outlook.

Krishna Institute of Medical Sciences Limited has informed the Exchange about Investor Presentation, which includes unaudited financial results for the 2nd quarter and half-year ended 30th September 2026.

Jayant Agro Organics Limited has announced unaudited financial results for the quarter and half-year ended September 30, 2026, and has enclosed a copy of the results along with the Limited Review Report issued by the Statutory Auditors.

Shashijit Infraprojects Ltd has announced its unaudited standalone financial results for the quarter and half year ended 30.09.2026, with the Board of Directors approving the results at its meeting held on 04.11.2026.

Toyam Sports Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/11/2026 to consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter and half year ended September 30, 2026.

Stel Holdings Limited has submitted its unaudited financial results for the quarter and half-year ended September 30, 2026, which were approved by the Board of Directors. The results are accompanied by a Limited Review Report issued by the Statutory Auditors.

KROWNIQ Ltd has announced its un-audited financial results for the second quarter ended 30th September, 2026, with a standalone profit of ₹126.98 crores. The company has also appointed Mr. Mahesh Sharma as the Company Secretary and Compliance Officer.

Premier Energies Ltd has released its Q2 FY27 financial results, showing a 38.2% YoY increase in revenue and a 17.8% YoY increase in EBITDA. The company has also highlighted its scale advantage, focused growth strategy, and technology leadership.

STEL Holdings Ltd has announced its unaudited financial results for the quarter and half-year ended September 30, 2026, with the Board of Directors approving the results and taking note of the Limited Review Reports issued by the Statutory Auditors.

Dr. Lal PathLabs Ltd has announced the availability of the audio recording of its earnings conference call for Q2 & H1 FY27 on its website.

Premier Energies Limited has informed the Exchange about Investor Presentation on Financial Results for the Quarter and Half Year Ended September 30, 2026 (Q2 FY27).

Aurobindo Pharma Ltd announced its Q2 FY27 financial results, with revenue from operations increasing by 24% YoY to INR 10,263 Cr, driven by growth across businesses. The company reported a net profit of INR 1,124 Cr and declared an interim dividend of ₹ 7.0 per share.